ScholarIQanswers from OpenAlex

Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy

PaperCitations, authors & open-access status

Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy have?

ScholarIQcitation count

Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy has 111 citations in the OpenAlex counts ScholarIQ stores.

When was Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy published?

ScholarIQyear

Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy has 2005 year in the ScholarIQ index.

What is the open-access status of Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy?

ScholarIQoa status

Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy has closed oa status in the ScholarIQ index.

What is the DOI of Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy?

ScholarIQdoi

The DOI for Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy is on the source record.

What is the PMID of Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy?

ScholarIQpmid

The PMID for Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy is on the source record.

What is the OpenAlex record for Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy?

ScholarIQopenalex

The OpenAlex for Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial